CYP3A422 and bleeding risk in ticagrelor users



Asiimwe, Innocent G ORCID: 0000-0002-1196-1822 and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2024) CYP3A422 and bleeding risk in ticagrelor users BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 134 (3). pp. 311-314. ISSN 1742-7835, 1742-7843

[thumbnail of Basic Clin Pharma Tox - 2024 - Asiimwe - CYP3A4 22 and bleeding risk in ticagrelor users.pdf] Text
Basic Clin Pharma Tox - 2024 - Asiimwe - CYP3A4 22 and bleeding risk in ticagrelor users.pdf - Author Accepted Manuscript
Available under License Creative Commons Attribution.

Download (751kB) | Preview
Item Type: Article
Uncontrolled Keywords: bleeding, CYP3A4, genome-wide association study, pharmacogenetics, ticagrelor
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology
Depositing User: Symplectic Admin
Date Deposited: 09 Jan 2024 11:23
Last Modified: 16 Jun 2026 20:03
DOI: 10.1111/bcpt.13977
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3177741
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.